| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0006-2952(00)00412-3 |
| P698 | PubMed publication ID | 11007957 |
| P2093 | author name string | Haegeman G | |
| Vermeulen L | |||
| Boone E | |||
| Vanden Berghe W | |||
| De Bosscher K | |||
| De Wilde G | |||
| P2860 | cites work | Structure of an IkappaBalpha/NF-kappaB complex | Q22008582 |
| CIR, a corepressor linking the DNA binding factor CBF1 to the histone deacetylase complex | Q22008610 | ||
| Functional role of p35srj, a novel p300/CBP binding protein, during transactivation by HIF-1 | Q22008661 | ||
| Composite co-activator ARC mediates chromatin-directed transcriptional activation | Q22009528 | ||
| The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators | Q22009958 | ||
| Requirement of Rsk-2 for epidermal growth factor-activated phosphorylation of histone H3 | Q22010472 | ||
| IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain | Q22010650 | ||
| NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase | Q22010870 | ||
| Inhibition of nuclear factor-kappaB-mediated transcription by association with the amino-terminal enhancer of split, a Groucho-related protein lacking WD40 repeats | Q22011204 | ||
| IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex | Q22254561 | ||
| I kappa B: a specific inhibitor of the NF-kappa B transcription factor | Q24296774 | ||
| Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations | Q24309222 | ||
| Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex | Q24324026 | ||
| Transcriptional activation of the integrated chromatin-associated human immunodeficiency virus type 1 promoter | Q24523709 | ||
| TAFII105 mediates activation of anti-apoptotic genes by NF-kappaB | Q24533311 | ||
| NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes | Q24534356 | ||
| Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit | Q24554482 | ||
| The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness | Q24554528 | ||
| CREB-binding protein/p300 are transcriptional coactivators of p65 | Q24569596 | ||
| Mitotic inactivation of a human SWI/SNF chromatin remodeling complex | Q24596960 | ||
| A histone deacetylase corepressor complex regulates the Notch signal transduction pathway | Q24598533 | ||
| The zinc finger protein A20 inhibits TNF-induced NF-kappaB-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal and directly binds to a novel NF-kappaB-inhibiting protein ABIN | Q24682087 | ||
| Solution Structure of the KIX Domain of CBP Bound to the Transactivation Domain of CREB: A Model for Activator:Coactivator Interactions | Q27748755 | ||
| The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation | Q27766393 | ||
| Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain | Q27860534 | ||
| The language of covalent histone modifications | Q27860931 | ||
| Regulation of transcription by a protein methyltransferase | Q28138085 | ||
| Recruitment of the IKK signalosome to the p55 TNF receptor: RIP and A20 bind to NEMO (IKKgamma) upon receptor stimulation | Q28141339 | ||
| DNA methyltransferase Dnmt1 associates with histone deacetylase activity | Q28141500 | ||
| Transcription factor-specific requirements for coactivators and their acetyltransferase functions | Q28260156 | ||
| Ionizing radiation and short wavelength UV activate NF-kappaB through two distinct mechanisms | Q36634373 | ||
| TAFII mutations disrupt Dorsal activation in the Drosophila embryo | Q36792176 | ||
| Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors | Q38289102 | ||
| Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. | Q38306725 | ||
| Inhibition of interleukin-1-stimulated NF-kappaB RelA/p65 phosphorylation by mesalamine is accompanied by decreased transcriptional activity | Q38320915 | ||
| Regulation of NF-kappaB RelA phosphorylation and transcriptional activity by p21(ras) and protein kinase Czeta in primary endothelial cells | Q38325239 | ||
| Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529. | Q38331909 | ||
| Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. | Q38331993 | ||
| I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. | Q38343666 | ||
| HIV-1 Tat induces the expression of the interleukin-6 (IL6) gene by binding to the IL6 leader RNA and by interacting with CAAT enhancer-binding protein beta (NF-IL6) transcription factors | Q38345146 | ||
| Glucocorticoid-mediated repression of NFkappaB activity in endothelial cells does not involve induction of IkappaBalpha synthesis | Q38354174 | ||
| Cooperation between phosphorylation and acetylation processes in transcriptional control | Q39445547 | ||
| Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB. | Q39451375 | ||
| Chromatin disruption and modification | Q39726920 | ||
| Transcription-independent phosphorylation of the RNA polymerase II C-terminal domain (CTD) involves ERK kinases (MEK1/2). | Q39729551 | ||
| Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway | Q40444275 | ||
| The pathophysiologic roles of interleukin-6 in human disease | Q40643111 | ||
| Initiation of acute phase response and synthesis of cytokines | Q40661106 | ||
| Transcription factors and asthma | Q40846857 | ||
| Interleukin-6 in biology and medicine | Q40850225 | ||
| Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis | Q40895421 | ||
| Rapid and selective remodeling of a positioned nucleosome during the induction of IL-12 p40 transcription | Q40907803 | ||
| CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling | Q40980349 | ||
| Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor | Q40981890 | ||
| Signal-specific co-activator domain requirements for Pit-1 activation | Q41006466 | ||
| CBP: a signal-regulated transcriptional coactivator controlled by nuclear calcium and CaM kinase IV. | Q41010869 | ||
| Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation | Q41038113 | ||
| p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. | Q41062073 | ||
| Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator | Q41133317 | ||
| NF-kappa B/Rel family members are physically associated phosphoproteins | Q41435410 | ||
| Roles of histone acetyltransferases and deacetylases in gene regulation | Q28286019 | ||
| The signal-dependent coactivator CBP is a nuclear target for pp90RSK | Q28286828 | ||
| The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-kappaB by directly targeting p65 | Q28290401 | ||
| TPL-2 kinase regulates the proteolysis of the NF-kappaB-inhibitory protein NF-kappaB1 p105 | Q28296740 | ||
| Interaction of the COOH-terminal transactivation domain of p65 NF-kappa B with TATA-binding protein, transcription factor IIB, and coactivators | Q28299369 | ||
| Chromium(VI) inhibits the transcriptional activity of nuclear factor-kappaB by decreasing the interaction of p65 with cAMP-responsive element-binding protein-binding protein | Q28377525 | ||
| CBP associates with the p42/p44 MAPK enzymes and is phosphorylated following NGF treatment | Q28572730 | ||
| Phosphorylation of NF-kappa B p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300 | Q28619230 | ||
| Cytokines in acute and chronic inflammation | Q28645928 | ||
| p38 MAPK signalling cascades in inflammatory disease | Q28678986 | ||
| Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription | Q29547568 | ||
| Activators and target genes of Rel/NF-kappaB transcription factors | Q29547882 | ||
| The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function | Q29547918 | ||
| Acetylation: a regulatory modification to rival phosphorylation? | Q29614886 | ||
| DNA damage activates p53 through a phosphorylation-acetylation cascade | Q29616294 | ||
| The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta | Q29617188 | ||
| Rad6-dependent ubiquitination of histone H2B in yeast | Q29617525 | ||
| Transcriptional activators direct histone acetyltransferase complexes to nucleosomes | Q29620509 | ||
| Signaling and circuitry of multiple MAPK pathways revealed by a matrix of global gene expression profiles | Q29620701 | ||
| The phosphorylation status of a cyclic AMP-responsive activator is modulated via a chromatin-dependent mechanism | Q30453590 | ||
| Analysis of an activator:coactivator complex reveals an essential role for secondary structure in transcriptional activation | Q31998382 | ||
| Histone acetylases and deacetylases in cell proliferation | Q33540069 | ||
| Multiple signals converging on NF-kappaB. | Q33597403 | ||
| Chromatin-modifying and -remodeling complexes | Q33632339 | ||
| RNA polymerase II as a control panel for multiple coactivator complexes | Q33632354 | ||
| Modifying chromatin and concepts of cancer | Q33632362 | ||
| Histone acetylation and cancer | Q33632377 | ||
| Tumor necrosis factor receptor and Fas signaling mechanisms. | Q33652491 | ||
| A firm hand on NFkappaB: structures of the IkappaBalpha-NFkappaB complex. | Q33658270 | ||
| Gene activation by histone and factor acetyltransferases | Q33680840 | ||
| Nuclear factor kappaB (NF-kappaB) pathway as a therapeutic target in rheumatoid arthritis | Q33685143 | ||
| The development and therapeutic potential of protein kinase inhibitors | Q33695725 | ||
| New targets for anti-inflammatory drugs | Q33695752 | ||
| Histone acetylation in signal transduction by growth regulatory signals | Q33707434 | ||
| MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction | Q33707440 | ||
| Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation | Q33708904 | ||
| Regulated phosphorylation of the RNA polymerase II C-terminal domain (CTD). | Q33765328 | ||
| Organization of chromatin in cancer cells: role of signalling pathways | Q33765339 | ||
| Novel approaches and targets for treatment of chronic obstructive pulmonary disease | Q33771480 | ||
| Dorsal-mediated repression requires the formation of a multiprotein repression complex at the ventral silencer. | Q33781523 | ||
| How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex | Q33797139 | ||
| Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway | Q33797156 | ||
| NF-kappaB activation and HIV-1 induced apoptosis | Q33824620 | ||
| NF-kappaB and the innate immune response | Q33840493 | ||
| CREB-independent regulation by CBP is a novel mechanism of human growth hormone gene expression | Q33859360 | ||
| The I kappa B/NF-kappa B system: a key determinant of mucosalinflammation and protection | Q33860197 | ||
| The IKK complex: an integrator of all signals that activate NF-kappaB? | Q33877083 | ||
| Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty | Q33896033 | ||
| Activation domain-specific and general transcription stimulation by native histone acetyltransferase complexes | Q33957284 | ||
| Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity | Q33957447 | ||
| Transcriptional activation by NF-kappaB requires multiple coactivators | Q33959552 | ||
| Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors | Q34021421 | ||
| Nuclear fusion of signaling pathways | Q34503399 | ||
| The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus | Q34543723 | ||
| Nuclear import of the Drosophila Rel protein Dorsal is regulated by phosphorylation | Q35190695 | ||
| Conversion of dorsal from an activator to a repressor by the global corepressor Groucho | Q35196355 | ||
| Histone acetyltransferases regulate HIV-1 enhancer activity in vitro | Q35199451 | ||
| Glucocorticoids repress NF-kappaB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell | Q35666145 | ||
| Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway | Q35952074 | ||
| Mitogen-activated protein kinases enhance long-range activation by the beta-globin locus control region | Q36217970 | ||
| Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects | Q36266899 | ||
| Regulation of p21(cip1) expression by growth factors and the extracellular matrix reveals a role for transient ERK activity in G1 phase | Q36301436 | ||
| Factor-specific modulation of CREB-binding protein acetyltransferase activity | Q36448157 | ||
| The interferon-inducible p202 protein as a modulator of transcription: inhibition of NF-kappa B, c-Fos, and c-Jun activities | Q36556883 | ||
| Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor | Q36569110 | ||
| Expression and up-regulation of interleukin-6 in oesophageal carcinoma cells by n-sodium butyrate | Q36620446 | ||
| Interleukin-6 (IL-6)--a molecule with both beneficial and destructive potentials | Q41597822 | ||
| Eukaryotic transcription: an interlaced network of transcription factors and chromatin-modifying machines | Q41708885 | ||
| The enhanceosome and transcriptional synergy. | Q41715800 | ||
| Chromatin and transcription--how transcription factors battle with a repressive chromatin environment | Q41716466 | ||
| Chromatin interaction mechanism of transcriptional control in vivo | Q41875311 | ||
| Role of NF-kappaB in immune and inflammatory responses in the gut. | Q41878721 | ||
| Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. | Q42140547 | ||
| A weak TATA box is a prerequisite for glucocorticoid-dependent repression of the osteocalcin gene | Q42447714 | ||
| Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein | Q42460228 | ||
| The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. | Q42479390 | ||
| Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV | Q42653589 | ||
| Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. | Q42824374 | ||
| Activation of SRF-regulated chromosomal templates by Rho-family GTPases requires a signal that also induces H4 hyperacetylation | Q42832063 | ||
| Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription | Q44445912 | ||
| Acetylation of HMG I(Y) by CBP turns off IFN beta expression by disrupting the enhanceosome | Q44646118 | ||
| The p300/CBP family: integrating signals with transcription factors and chromatin | Q45155861 | ||
| Virus infection leads to localized hyperacetylation of histones H3 and H4 at the IFN-beta promoter | Q45178460 | ||
| Allosteric effects of DNA on transcriptional regulators | Q46483901 | ||
| Co-activators and co-repressors in the integration of transcriptional responses | Q46623959 | ||
| JIL-1: a novel chromosomal tandem kinase implicated in transcriptional regulation in Drosophila | Q47072002 | ||
| Cross-talk between steroids and NF-kappa B: what language? | Q47714581 | ||
| Sesquiterpene lactone containing Mexican Indian medicinal plants and pure sesquiterpene lactones as potent inhibitors of transcription factor NF-kappaB. | Q47803095 | ||
| Long-range transcriptional regulation of cytokine gene expression | Q47933670 | ||
| Gene silencing. Methylation meets acetylation | Q47991752 | ||
| Conjunction dysfunction: CBP/p300 in human disease. | Q48013074 | ||
| Nuclear factor-kappaB/Rel proteins: a point of convergence of signalling pathways relevant in neuronal function and dysfunction | Q48298914 | ||
| Inactivation of p42 mitogen-activated protein kinase is required for exit from M-phase after cyclin destruction | Q48906664 | ||
| Two tumour necrosis factor receptors: structure and function. | Q49167492 | ||
| Activation of the nuclear factor kappa B is not sufficient for regulation of tumor necrosis factor-induced interleukin-6 gene expression | Q49168800 | ||
| Drosophila CBP is required for dorsal-dependent twist gene expression. | Q52192359 | ||
| Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. | Q52538241 | ||
| An exceptionally well-preserved theropod dinosaur from the Yixian Formation of China | Q55869278 | ||
| Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1 | Q57244351 | ||
| Signal transduction: A central control for cell growth | Q58415326 | ||
| A new target for aspirin | Q59060572 | ||
| Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha | Q71513462 | ||
| Tumor necrosis factor-alpha-dependent activation of a RelA homodimer in astrocytes. Increased phosphorylation of RelA and MAD-3 precede activation of RelA | Q72536355 | ||
| Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells | Q73075184 | ||
| The p38 mitogen-activated protein kinase is required for NF-kappaB-dependent gene expression. The role of TATA-binding protein (TBP) | Q73083269 | ||
| Emerging targets for anti-inflammatory therapy | Q73177743 | ||
| Activation of nuclear transcription factor NF-kappaB by interleukin-1 is accompanied by casein kinase II-mediated phosphorylation of the p65 subunit | Q73956120 | ||
| Chromatin remodeling: a marriage between two families? | Q77570570 | ||
| Nerve growth factor up-regulates the transcriptional activity of CBP through activation of the p42/p44(MAPK) cascade | Q77604380 | ||
| Nuclear factor kappa B: a pivotal role in the systemic inflammatory response syndrome and new target for therapy | Q77757835 | ||
| Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation | Q77769108 | ||
| Pharmacological modulation of cytokine action and production through signaling pathways | Q77903807 | ||
| Innovative treatment programs against cancer: II. Nuclear factor-kappaB (NF-kappaB) as a molecular target | Q77910102 | ||
| Transcription: Common cofactors and cooperative recruitment | Q78198301 | ||
| Gene-regulating protein kinases as important anti-inflammatory targets | Q78240850 | ||
| How chromatin changes its shape | Q78254094 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | interleukins | Q194908 |
| P304 | page(s) | 1185-1195 | |
| P577 | publication date | 2000-10-01 | |
| P1433 | published in | Biochemical Pharmacology | Q864229 |
| P1476 | title | Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. | |
| P478 | volume | 60 |
| Q34115914 | A fully dissociated compound of plant origin for inflammatory gene repression |
| Q44509573 | A(2B) adenosine receptors increase cytokine release by bronchial smooth muscle cells. |
| Q86049599 | Abrogation of galectin-4 expression promotes tumorigenesis in colorectal cancer |
| Q34170097 | Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches |
| Q44809819 | Activated hepatic stellate cells mediate the differentiation of macrophages |
| Q28366026 | Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes |
| Q36325539 | Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy |
| Q42471925 | Adiponectin inhibits LPS-induced NF-kappaB activation and IL-6 production and increases PPARgamma2 expression in adipocytes |
| Q40220071 | Alterations of metabolic activity in human osteoarthritic osteoblasts by lipid peroxidation end product 4-hydroxynonenal |
| Q37239169 | An asthma-associated IL4R variant exacerbates airway inflammation by promoting conversion of regulatory T cells to TH17-like cells |
| Q35671757 | Aortic perivascular adipose-derived interleukin-6 contributes to arterial stiffness in low-density lipoprotein receptor deficient mice |
| Q36623323 | Are there race-dependent endothelial cell responses to exercise? |
| Q89284693 | Association between the -174 C/G polymorphism in the interleukin-6 (IL-6) gene and gastrointestinal involvement in patients with systemic sclerosis |
| Q24644700 | BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells |
| Q24309171 | Bacterial induction of TNF-alpha converting enzyme expression and IL-6 receptor alpha shedding regulates airway inflammatory signaling |
| Q43589230 | Baseline TNFα operational capacity in fetal and maternal circulation prior to the onset of labor: "tuned for different purposes". |
| Q38572902 | Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors |
| Q44372580 | Caspase inhibition causes hyperacute tumor necrosis factor-induced shock via oxidative stress and phospholipase A2. |
| Q39137409 | Chrysoeriol isolated from Eurya cilliata leaves protects MC3T3‐E1 cells against hydrogen peroxide‐induced inhibition of osteoblastic differentiation |
| Q74228648 | Cobalamin (vitamin B(12)) positively regulates interleukin-6 levels in rat cerebrospinal fluid |
| Q34147790 | Conjugated linoleic acid promotes human adipocyte insulin resistance through NFkappaB-dependent cytokine production. |
| Q30805616 | Cytokine-related genes identified from the RIKEN full-length mouse cDNA data set |
| Q45888093 | Cytoplasmic deposition of NFkappaB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation |
| Q35901274 | Differential Expression of the Activator Protein 1 Transcription Factor Regulates Interleukin-1ß Induction of Interleukin 6 in the Developing Enterocyte |
| Q28546223 | Differential cytokine profiles upon comparing selective versus classic glucocorticoid receptor modulation in human peripheral blood mononuclear cells and inferior turbinate tissue |
| Q40335724 | Differential cytokine responses from primary human Kupffer cells following infection with wild-type or vaccine strain yellow fever virus |
| Q47130264 | EMMPRIN Inhibits bFGF-Induced IL-6 Secretion in an Osteoblastic Cell Line, MC3T3-E1. |
| Q40731921 | Effect of glycated albumin and cranberry components on interleukin-6 and matrix metalloproteinase-3 production by human gingival fibroblasts |
| Q41819465 | Effect of hydrogen sulfide on inflammatory cytokines in acute myocardial ischemia injury in rats |
| Q33883171 | Effects of IL-6 on pyruvate dehydrogenase regulation in mouse skeletal muscle |
| Q38320429 | Effects of cranberry components on human aggressive periodontitis gingival fibroblasts |
| Q35840719 | Effects of short-term glucocorticoid treatment on changes in cartilage matrix degradation and chondrocyte gene expression induced by mechanical injury and inflammatory cytokines |
| Q28580800 | Endogenous protein kinase inhibitor gamma terminates immediate-early gene expression induced by cAMP-dependent protein kinase (PKA) signaling: termination depends on PKA inactivation rather than PKA export from the nucleus |
| Q36838268 | Endothelial activation microparticles and inflammation status improve with exercise training in african americans. |
| Q37019560 | Endotoxin-Induced IL-6 Promoter Activation in Skeletal Muscle Requires an NF-κB Site |
| Q42061656 | Essential role of pre-B-cell colony enhancing factor in ventilator-induced lung injury |
| Q35103246 | FLICE-like inhibitory protein (FLIP) protects against apoptosis and suppresses NF-kappaB activation induced by bacterial lipopolysaccharide |
| Q44628151 | Formyl-Met-Leu-Phe induces calcium-dependent tyrosine phosphorylation of Rel-1 in neutrophils |
| Q40619563 | Functional Cooperation between Interleukin-17 and Tumor Necrosis Factor-α Is Mediated by CCAAT/Enhancer-binding Protein Family Members |
| Q36354844 | Genetic polymorphism directs IL-6 expression in fibroblasts but not selected other cell types. |
| Q35921093 | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis |
| Q38843459 | Ghrelin Inhibits Interleukin-6 Production Induced by Cigarette Smoke Extract in the Bronchial Epithelial Cell Via NF-κB Pathway |
| Q44185696 | Glucocorticoids aggravate hyperoxia-induced lung injury through decreased nuclear factor-kappa B activity |
| Q35093797 | Glucocorticoids: new mechanisms and future agents |
| Q36201174 | Heat shock protein 70 and the acute respiratory distress syndrome |
| Q39780647 | High white blood cell count and low estimated glomerular filtration rate are independently associated with serum level of monocyte chemoattractant protein-1 in a general population |
| Q39900346 | Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway. |
| Q40689433 | Hyperthermia-induced heat shock activates the transcription factor c/EBP-beta and augments IL-6 production in human intestinal epithelial cells |
| Q36110505 | IFN-γ synergistically enhances LPS signalling in alveolar macrophages from COPD patients and controls by corticosteroid-resistant STAT1 activation |
| Q40658337 | IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B. |
| Q35574918 | Increased HCMV seroprevalence in patients with hepatocellular carcinoma |
| Q40265640 | Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway. |
| Q37041320 | Influence of Promoter Polymorphisms of the TNF-α (-308G/A) and IL-6 (-174G/C) Genes on Therapeutic Response to Etanercept in Rheumatoid Arthritis |
| Q28547157 | Inhibition of IL-6 signaling pathway by curcumin in uterine decidual cells |
| Q74498900 | Inhibition of inflammatory cytokine production and lymphocyte proliferation by structurally different sesquiterpene lactones correlates with their effect on activation of NF-kappaB |
| Q38313361 | Inhibition of interleukin 1β-stimulated interleukin-6 production by cranberry components in human gingival epithelial cells: effects on nuclear factor κB and activator protein 1 activation pathways |
| Q42010475 | Interleukin (IL) 1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase-dependent AKT/IkappaB kinase alpha pathway targeting activator protein-1. |
| Q52849175 | Interleukin-1alpha stimulates proinflammatory cytokine expression in human cardiac myofibroblasts. |
| Q42833395 | Interleukin-6 and interleukin-15 are selectively regulated by lipopolysaccharide and interferon-gamma in primary pig adipocytes |
| Q41340132 | Interleukin-6 as a prognostic marker in dogs in an intensive care unit |
| Q36543680 | Interleukin-6/signal transducer and activator of transcription 3 (STAT3) pathway is essential for macrophage infiltration and myoblast proliferation during muscle regeneration |
| Q43294444 | Link between plasma ceramides, inflammation and insulin resistance: association with serum IL-6 concentration in patients with coronary heart disease |
| Q57464772 | Loss of DBC1 (CCAR2) affects TNFα-induced lipolysis and gene expression in murine adipocytes |
| Q37238463 | Manipulation of gene expression by oxygen: a primer from bedside to bench |
| Q39800997 | MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines |
| Q44386928 | Mechanism of the salutary effects of 17beta-estradiol following trauma-hemorrhage: direct downregulation of Kupffer cell proinflammatory cytokine production |
| Q36674821 | Metabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome? |
| Q36870550 | MiR-26 down-regulates TNF-α/NF-κB signalling and IL-6 expression by silencing HMGA1 and MALT1. |
| Q35234933 | MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38. |
| Q79369723 | Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50 |
| Q34614244 | Mucosal and enterocyte IL-6 production during sepsis and endotoxemia--role of transcription factors and regulation by the stress response |
| Q40698036 | Multiple transcription factors regulating the IL-6 gene are activated by cAMP in cultured Caco-2 cells |
| Q39619714 | PEDF in diabetic retinopathy: a protective effect of oxidative stress. |
| Q34731078 | Perspectives for TNF-alpha-targeting therapies |
| Q34934915 | Pharmaco-redox regulation of cytokine-related pathways: from receptor signaling to pharmacogenomics |
| Q35911768 | Pharmacological inhibition of caspase-8 limits lung tumour outgrowth. |
| Q43900414 | Premature coronary heart disease in SLE: can we prevent progression? |
| Q43527544 | Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer |
| Q40744807 | Proteasome inhibitors induce heat shock response and increase IL-6 expression in human intestinal epithelial cells |
| Q35233331 | Racial differences in tumor necrosis factor-α-induced endothelial microparticles and interleukin-6 production |
| Q40508670 | Regulation of IL-6 in Immunity and Diseases. |
| Q34049840 | Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori |
| Q44597273 | Regulation of microglial inflammatory response by histone deacetylase inhibitors |
| Q40290650 | Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism |
| Q34304772 | Rev-erbalpha upregulates NF-kappaB-responsive genes in vascular smooth muscle cells |
| Q44777453 | Role of FAN in tumor necrosis factor-alpha and lipopolysaccharide-induced interleukin-6 secretion and lethality in D-galactosamine-sensitized mice |
| Q27009263 | Role of interleukin-6 in Barrett's esophagus pathogenesis |
| Q46867979 | Role of the JNK signaling pathway in downregulation of connexin43 by TNF-α in human corneal fibroblasts |
| Q37466941 | SD0006: a potent, selective and orally available inhibitor of p38 kinase |
| Q24804939 | SLE - Complex cytokine effects in a complex autoimmune disease: tumor necrosis factor in systemic lupus erythematosus |
| Q31022986 | Similar NF-κB gene signatures in TNF-α treated human endothelial cells and breast tumor biopsies. |
| Q35704561 | Sleep apnea determines soluble TNF-α receptor 2 response to massive weight loss |
| Q44605779 | Sodium arsenite downregulates transcriptional activity of AP‐1 and CRE binding proteins in IL‐1β‐treated Caco‐2 cells by increasing the expression of the transcriptional repressor CREMα |
| Q34571684 | Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism |
| Q40692623 | Steroid responsiveness of renal epithelial cells. Dissociation of transrepression and transactivation |
| Q41828178 | Stimulation with Peptidoglycan induces interleukin 6 and TLR2 expression and a concomitant downregulation of expression of adiponectin receptors 1 and 2 in 3T3-L1 adipocytes |
| Q92308568 | Study on the Multitarget Mechanism and Key Active Ingredients of Herba Siegesbeckiae and Volatile Oil against Rheumatoid Arthritis Based on Network Pharmacology |
| Q35032919 | Sympathetic nervous system interaction with the immune system |
| Q35637328 | Synthesis of benzothiophene-based hydroxamic acids as potent and selective HDAC6 inhibitors |
| Q48362769 | TNF stimulates IL-6, CXCL8 and VEGF secretion from human keratinocytes via activation of mTOR, inhibited by tetramethoxyluteolin |
| Q84511689 | The -174 G/C polymorphism in interleukin-6 (IL-6) promoter region is associated with serum IL-6 and carcinoembryonic antigen levels in patients with colorectal cancers in Taiwan |
| Q24551184 | The Fas-associated death domain protein suppresses activation of NF-kappa B by LPS and IL-1 beta |
| Q34520132 | The duality of the inflammatory response to traumatic brain injury |
| Q41970723 | The effect of ROCK on TNF-α-induced CXCL8 secretion by intestinal epithelial cell lines is mediated through MKK4 and JNK signaling |
| Q35011136 | The interferon-gamma-induced GTPase, mGBP-2, inhibits tumor necrosis factor alpha (TNF-alpha) induction of matrix metalloproteinase-9 (MMP-9) by inhibiting NF-kappaB and Rac protein |
| Q42271874 | The role of Mcl-1 in S. aureus-induced cytoprotection of infected macrophages |
| Q28586254 | The role of interleukin 1 receptor-associated kinase-4 (IRAK-4) kinase activity in IRAK-4-mediated signaling |
| Q40478245 | Tissue factor haploinsufficiency during endotoxin induced coagulation and inflammation in mice. |
| Q40718510 | Transcription factors C/EBP-beta and -delta regulate IL-6 production in IL-1beta-stimulated human enterocytes |
| Q24297420 | Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1) |
| Q40660807 | Tumor necrosis factor alpha (TNF-alpha)-induced RANTES chemokine expression via activation of NF-kappaB and p38 MAP kinase: roles of TNF-alpha in alcoholic liver diseases |
| Q38359877 | Tumor necrosis factor receptor 1 induces interleukin-6 upregulation through NF-kappaB in a rat neuropathic pain model |
| Q34792814 | Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease |
| Q40144959 | Tumor necrosis factor-alpha stimulates focal adhesion kinase activity required for mitogen-activated kinase-associated interleukin 6 expression |
| Q38068175 | Understanding the neuroinflammatory response following concussion to develop treatment strategies |
| Q33686393 | Upregulation of Salmonella-induced IL-6 production in Caco-2 cells by PJ-34, PARP-1 inhibitor: involvement of PI3K, p38 MAPK, ERK, JNK, and NF-kappaB |
| Q36772368 | Zinc-gene interaction related to inflammatory/immune response in ageing. |
| Q34889343 | c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. |
Search more.